20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with dimethylarginine in 1 studies
Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (dimethylarginine) | Trials (dimethylarginine) | Recent Studies (post-2010) (dimethylarginine) |
---|---|---|---|---|---|
640 | 13 | 233 | 519 | 53 | 244 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bolad, I; Delafontaine, P | 1 |
1 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and dimethylarginine
Article | Year |
---|---|
Endothelial dysfunction: its role in hypertensive coronary disease.
Topics: Angiotensin II; Antihypertensive Agents; Arginine; Coronary Disease; Endothelium, Vascular; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Nitric Oxide; Oxidants | 2005 |